LI
Leslie's, Inc. (LESL)·Q3 2024 Earnings Summary
Executive Summary
- Q3 2024 sales were $569.6M, down 6.8% YoY; diluted EPS $0.33 (adjusted $0.34); gross margin 40.2% vs 41.2% LY; adjusted EBITDA $109.5M .
- Management said results met revised expectations from the July 17 preliminary release, with June trends improving (chemical volume positive; discretionary down 10% in quarter but only 5% in June) .
- Full-year FY2024 guidance was cut on July 17 and reaffirmed: sales $1.321–$1.347B, adjusted EBITDA $117–$131M, adjusted EPS $0.03–$0.09; prior guide was $1.410–$1.470B sales, adjusted EBITDA $170–$190M, adjusted EPS $0.25–$0.33 .
- Street consensus from S&P Global was unavailable at the time of analysis; therefore explicit beat/miss vs estimates cannot be quantified. Company-outlined catalysts: improved June demand and cost/inventory actions; plus a CEO transition announced Aug 26 may be a narrative catalyst near-term .
What Went Well and What Went Wrong
What Went Well
- June inflection: total sales down 2% in June vs down 7% in Q3; chemicals down 1% in Q3 and up mid-single digits in June; chemical volume positive YTD .
- Cost/inventory discipline: SG&A down 3% YoY in Q3; inventory down 31% YoY to $302M with strong in-stock/service/NPS; cash rose to $74M; no revolver drawn .
- Strategic initiatives: PRO contracts grew to 4,254 and locations to 108; AccuBlue Home adoption strong with members spending >$1,000/year .
What Went Wrong
- Weather and macro headwinds: cold/wet April–May delayed season; discretionary weakness from inflation and high rates; traffic down 5% in Q3, transactions down 2% .
- Gross margin compression: 40.2% vs 41.2% LY due to June 2023 chemical price actions (≈112 bps headwind), occupancy deleverage, and expensing capitalized DC costs; adjusted EBITDA down to $109.5M from $129.0M LY .
- Equipment softness: equipment sales down 15% as consumers deferred big-ticket purchases; discretionary products down 10% in Q3 .
Financial Results
Quarterly progression (Q1–Q3 FY2024)
Year-over-year (Q3 FY2024 vs Q3 FY2023)
Segment/Category performance (Q3 FY2024)
KPIs and operating metrics
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- “Total sales improved to down 7% in the third quarter from down 11% in the first half… Within the quarter, sales in June improved to down 2%. Chemical sales improved to down 1% in the quarter and up 5% in June.” — CEO Mike Egeck
- “Gross margin was 40%, down 101 bps YoY… includes a 112 bps impact from the June 2023 chemical price actions, occupancy deleverage… and the expensing of capitalized DC costs.” — CEO Mike Egeck
- “We ended the quarter with 4,254 PRO contracts and 108 PRO locations… AccuBlue Home… members continue to spend at a rate of more than $1,000 per year.” — CEO Mike Egeck
- “We expect Q4 adjusted EBITDA to be $51–$65M and adjusted diluted EPS $0.06–$0.12… end FY with cash $75–$80M; leverage ratio 5.4x–6.0x.” — CFO Scott Bowman
Q&A Highlights
- Bridging the Q3 guide miss: guide assumed transactions +4% and AOV −4%; actual transactions −2% and AOV −5%, with traffic −5% entirely driving the miss (weather/cautious consumer/normalization) .
- Gross margin path: 40% LT vs 41% pre-COVID due to mix shift (PRO/hot tub/digital) and improving process/tools; expect back-half margin expansion as price actions lap and rebates normalize .
- Market share and pricing: pricing rational/stable; June credit card and SimilarWeb data suggested share gains vs specialty peers; focus on maintaining price position above mass, at/below specialty .
- Equipment and hot tubs: equipment down 15% as consumers fix vs replace; hot tub order book healthy and deliveries improved as weather normalized .
- Capital allocation: prioritize debt paydown before faster store growth; target leverage ≤3x LT; Q3 effective term loan rate 8.2% .
Estimates Context
- Wall Street consensus (S&P Global) for Q3 2024 EPS and revenue was unavailable at the time of request due to provider limits; explicit beat/miss cannot be quantified. Values retrieved from S&P Global were unavailable.
- Company emphasized results were in line with revised expectations from the July 17 preliminary release; June momentum supports Q4 outlook ranges .
Key Takeaways for Investors
- Seasonality reset but June inflection: June demand improved materially, with chemicals positive and discretionary less negative; watch Q4 as price-action headwinds fully lap and new lower-cost inventory flows, supporting margin recovery .
- Mix matters: PRO growth and digital dilute gross margin vs residential but enhance EBITDA; expect continued mix-driven margin differences vs pre-COVID (40% vs 41%) .
- Balance sheet progress: inventory down 31% YoY; cash up to $74M; revolver fully undrawn; term loan effective rate 8.2%; leverage ~5.7x—deleveraging remains priority and potential multiple catalyst if execution continues .
- Discretionary/equipment weakness likely transitory: big-ticket deferrals reflect macro; equipment unit volumes back to 2019 levels, suggesting normalization base for 2025 .
- Guidance reset: FY2024 guide cut and reaffirmed; set expectations accordingly—focus near term on execution in Q4; LT targets include mid-single-digit sales growth, ~40% gross margin, mid-teens adjusted EBITDA margin when demand normalizes .
- Strategic moats: AccuBlue Home and Pool Perks loyalty drive higher conversion and spending; PRO partner program expanding; these should support share gains as conditions normalize .
- Potential narrative catalyst: CEO transition announced Aug 26 may prompt strategic refresh; monitor early signals and any FY2025 framework changes .